Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.

Minerva ginecologica - 1 Dec 2009

Baumann C K, Castiglione-Gertsch M

Abstract excerpt

Selective estrogen receptor modulators (SERMs) and selective estrogen down regulators (SERDs) act as estrogen receptor (ER) agonists or antagonist depending on the targeted tissue and the specific configuration of the used SERM or SERD. Effects on bone, endometrium and breast cancer are of interest. Endocrine treatments have been used in breast cancer since the end of the 19th century. In the second part of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Aromatase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy, Adjuvant

Share to Fulvestrant

Share to Neoadjuvant Therapy

Share to Selective Estrogen Receptor Modulators

Share to Tamoxifen

Share to Triazoles

Source

Identifiers

PMID: 19942839

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.PMID 19942839Read ↗

Antiestrogens: structure-activity relationships and use in breast cancer treatment.Semantic proximity Read ↗

Molecular Changes During Breast Cancer and Mechanisms of Endocrine Therapy Resistance.Semantic proximity Read ↗

[Estrogen receptor].Semantic proximity Read ↗

Tamoxifen metabolism in breast cancer treatment: Taking the focus off the CYP2D6 gene.Semantic proximity Read ↗

Overview of the therapeutic strategies for ER positive breast cancer.Semantic proximity Read ↗

Oral SERD, A Novel Endocrine Therapy for Estrogen Receptor-Positive Breast CancerSemantic proximity Read ↗

Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to TreatmentSemantic proximity Read ↗

Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifenSemantic proximity Read ↗

Estrogen receptor and breast cancer.Semantic proximity Read ↗

Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child.Semantic proximity Read ↗

Estetrol and Mammary Gland: Friends or Foes?Semantic proximity Read ↗

Tamoxifen metabolism and its effect on endocrine treatment of breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.